Global mRNA Vaccines & Therapeutics Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global mRNA Vaccines & Therapeutics market size is predicted to grow from US$ 3329 million in 2025 to US$ 1299 million in 2031; it is expected to grow at a CAGR of -14.5% from 2025 to 2031.
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
Global core mRNA vaccines & therapeutics manufacturers include Moderna Therapeutics, CureVac etc. The top 3 companies hold a share about 65%. Europe is the largest market, with a share about 10%, followed by Asia Pacific and North America.
LP Information, Inc. (LPI) ' newest research report, the “mRNA Vaccines & Therapeutics Industry Forecast” looks at past sales and reviews total world mRNA Vaccines & Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected mRNA Vaccines & Therapeutics sales for 2025 through 2031. With mRNA Vaccines & Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Vaccines & Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global mRNA Vaccines & Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on mRNA Vaccines & Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global mRNA Vaccines & Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Vaccines & Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Vaccines & Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Vaccines & Therapeutics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global mRNA Vaccines & Therapeutics market?
What factors are driving mRNA Vaccines & Therapeutics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do mRNA Vaccines & Therapeutics market opportunities vary by end market size?
How does mRNA Vaccines & Therapeutics break out by Type, by Application?
The global mRNA Vaccines & Therapeutics market size is predicted to grow from US$ 3329 million in 2025 to US$ 1299 million in 2031; it is expected to grow at a CAGR of -14.5% from 2025 to 2031.
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
Global core mRNA vaccines & therapeutics manufacturers include Moderna Therapeutics, CureVac etc. The top 3 companies hold a share about 65%. Europe is the largest market, with a share about 10%, followed by Asia Pacific and North America.
LP Information, Inc. (LPI) ' newest research report, the “mRNA Vaccines & Therapeutics Industry Forecast” looks at past sales and reviews total world mRNA Vaccines & Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected mRNA Vaccines & Therapeutics sales for 2025 through 2031. With mRNA Vaccines & Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Vaccines & Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global mRNA Vaccines & Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on mRNA Vaccines & Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global mRNA Vaccines & Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Vaccines & Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Vaccines & Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Vaccines & Therapeutics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Infectious Disease Vaccines
- Cancer Vaccines
- Infectious Disease
- Cancer
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Moderna Therapeutics
- CureVac
- Translate Bio
- BioNTech
- Sangamo Therapeutics
- Argos Therapeutics
- In-Cell-Art
- eTheRNA
- Ethris
- Tiba Biotechnology
What is the 10-year outlook for the global mRNA Vaccines & Therapeutics market?
What factors are driving mRNA Vaccines & Therapeutics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do mRNA Vaccines & Therapeutics market opportunities vary by end market size?
How does mRNA Vaccines & Therapeutics break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global mRNA Vaccines & Therapeutics Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for mRNA Vaccines & Therapeutics by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for mRNA Vaccines & Therapeutics by Country/Region, 2020, 2024 & 2031
2.2 mRNA Vaccines & Therapeutics Segment by Type
2.2.1 Infectious Disease Vaccines
2.2.2 Cancer Vaccines
2.3 mRNA Vaccines & Therapeutics Sales by Type
2.3.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2020-2025)
2.3.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2020-2025)
2.3.3 Global mRNA Vaccines & Therapeutics Sale Price by Type (2020-2025)
2.4 mRNA Vaccines & Therapeutics Segment by Application
2.4.1 Infectious Disease
2.4.2 Cancer
2.5 mRNA Vaccines & Therapeutics Sales by Application
2.5.1 Global mRNA Vaccines & Therapeutics Sale Market Share by Application (2020-2025)
2.5.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Application (2020-2025)
2.5.3 Global mRNA Vaccines & Therapeutics Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global mRNA Vaccines & Therapeutics Breakdown Data by Company
3.1.1 Global mRNA Vaccines & Therapeutics Annual Sales by Company (2020-2025)
3.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Company (2020-2025)
3.2 Global mRNA Vaccines & Therapeutics Annual Revenue by Company (2020-2025)
3.2.1 Global mRNA Vaccines & Therapeutics Revenue by Company (2020-2025)
3.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Company (2020-2025)
3.3 Global mRNA Vaccines & Therapeutics Sale Price by Company
3.4 Key Manufacturers mRNA Vaccines & Therapeutics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers mRNA Vaccines & Therapeutics Product Location Distribution
3.4.2 Players mRNA Vaccines & Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MRNA VACCINES & THERAPEUTICS BY GEOGRAPHIC REGION
4.1 World Historic mRNA Vaccines & Therapeutics Market Size by Geographic Region (2020-2025)
4.1.1 Global mRNA Vaccines & Therapeutics Annual Sales by Geographic Region (2020-2025)
4.1.2 Global mRNA Vaccines & Therapeutics Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic mRNA Vaccines & Therapeutics Market Size by Country/Region (2020-2025)
4.2.1 Global mRNA Vaccines & Therapeutics Annual Sales by Country/Region (2020-2025)
4.2.2 Global mRNA Vaccines & Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas mRNA Vaccines & Therapeutics Sales Growth
4.4 APAC mRNA Vaccines & Therapeutics Sales Growth
4.5 Europe mRNA Vaccines & Therapeutics Sales Growth
4.6 Middle East & Africa mRNA Vaccines & Therapeutics Sales Growth
5 AMERICAS
5.1 Americas mRNA Vaccines & Therapeutics Sales by Country
5.1.1 Americas mRNA Vaccines & Therapeutics Sales by Country (2020-2025)
5.1.2 Americas mRNA Vaccines & Therapeutics Revenue by Country (2020-2025)
5.2 Americas mRNA Vaccines & Therapeutics Sales by Type (2020-2025)
5.3 Americas mRNA Vaccines & Therapeutics Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Vaccines & Therapeutics Sales by Region
6.1.1 APAC mRNA Vaccines & Therapeutics Sales by Region (2020-2025)
6.1.2 APAC mRNA Vaccines & Therapeutics Revenue by Region (2020-2025)
6.2 APAC mRNA Vaccines & Therapeutics Sales by Type (2020-2025)
6.3 APAC mRNA Vaccines & Therapeutics Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe mRNA Vaccines & Therapeutics by Country
7.1.1 Europe mRNA Vaccines & Therapeutics Sales by Country (2020-2025)
7.1.2 Europe mRNA Vaccines & Therapeutics Revenue by Country (2020-2025)
7.2 Europe mRNA Vaccines & Therapeutics Sales by Type (2020-2025)
7.3 Europe mRNA Vaccines & Therapeutics Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa mRNA Vaccines & Therapeutics by Country
8.1.1 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Country (2020-2025)
8.1.2 Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country (2020-2025)
8.2 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Type (2020-2025)
8.3 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of mRNA Vaccines & Therapeutics
10.3 Manufacturing Process Analysis of mRNA Vaccines & Therapeutics
10.4 Industry Chain Structure of mRNA Vaccines & Therapeutics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 mRNA Vaccines & Therapeutics Distributors
11.3 mRNA Vaccines & Therapeutics Customer
12 WORLD FORECAST REVIEW FOR MRNA VACCINES & THERAPEUTICS BY GEOGRAPHIC REGION
12.1 Global mRNA Vaccines & Therapeutics Market Size Forecast by Region
12.1.1 Global mRNA Vaccines & Therapeutics Forecast by Region (2026-2031)
12.1.2 Global mRNA Vaccines & Therapeutics Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global mRNA Vaccines & Therapeutics Forecast by Type (2026-2031)
12.7 Global mRNA Vaccines & Therapeutics Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Moderna Therapeutics
13.1.1 Moderna Therapeutics Company Information
13.1.2 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Portfolios and Specifications
13.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Moderna Therapeutics Main Business Overview
13.1.5 Moderna Therapeutics Latest Developments
13.2 CureVac
13.2.1 CureVac Company Information
13.2.2 CureVac mRNA Vaccines & Therapeutics Product Portfolios and Specifications
13.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 CureVac Main Business Overview
13.2.5 CureVac Latest Developments
13.3 Translate Bio
13.3.1 Translate Bio Company Information
13.3.2 Translate Bio mRNA Vaccines & Therapeutics Product Portfolios and Specifications
13.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Translate Bio Main Business Overview
13.3.5 Translate Bio Latest Developments
13.4 BioNTech
13.4.1 BioNTech Company Information
13.4.2 BioNTech mRNA Vaccines & Therapeutics Product Portfolios and Specifications
13.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 BioNTech Main Business Overview
13.4.5 BioNTech Latest Developments
13.5 Sangamo Therapeutics
13.5.1 Sangamo Therapeutics Company Information
13.5.2 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Portfolios and Specifications
13.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Sangamo Therapeutics Main Business Overview
13.5.5 Sangamo Therapeutics Latest Developments
13.6 Argos Therapeutics
13.6.1 Argos Therapeutics Company Information
13.6.2 Argos Therapeutics mRNA Vaccines & Therapeutics Product Portfolios and Specifications
13.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Argos Therapeutics Main Business Overview
13.6.5 Argos Therapeutics Latest Developments
13.7 In-Cell-Art
13.7.1 In-Cell-Art Company Information
13.7.2 In-Cell-Art mRNA Vaccines & Therapeutics Product Portfolios and Specifications
13.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 In-Cell-Art Main Business Overview
13.7.5 In-Cell-Art Latest Developments
13.8 eTheRNA
13.8.1 eTheRNA Company Information
13.8.2 eTheRNA mRNA Vaccines & Therapeutics Product Portfolios and Specifications
13.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 eTheRNA Main Business Overview
13.8.5 eTheRNA Latest Developments
13.9 Ethris
13.9.1 Ethris Company Information
13.9.2 Ethris mRNA Vaccines & Therapeutics Product Portfolios and Specifications
13.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Ethris Main Business Overview
13.9.5 Ethris Latest Developments
13.10 Tiba Biotechnology
13.10.1 Tiba Biotechnology Company Information
13.10.2 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Portfolios and Specifications
13.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Tiba Biotechnology Main Business Overview
13.10.5 Tiba Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. mRNA Vaccines &Therapeutics Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. mRNA Vaccines &Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Infectious Disease Vaccines
Table 4. Major Players of Cancer Vaccines
Table 5. Global mRNA Vaccines &Therapeutics Sales byType (2020-2025) & (M Doses)
Table 6. Global mRNA Vaccines &Therapeutics Sales Market Share byType (2020-2025)
Table 7. Global mRNA Vaccines &Therapeutics Revenue byType (2020-2025) & ($ million)
Table 8. Global mRNA Vaccines &Therapeutics Revenue Market Share byType (2020-2025)
Table 9. Global mRNA Vaccines &Therapeutics Sale Price byType (2020-2025) & (USD/Doses)
Table 10. Global mRNA Vaccines &Therapeutics Sale by Application (2020-2025) & (M Doses)
Table 11. Global mRNA Vaccines &Therapeutics Sale Market Share by Application (2020-2025)
Table 12. Global mRNA Vaccines &Therapeutics Revenue by Application (2020-2025) & ($ million)
Table 13. Global mRNA Vaccines &Therapeutics Revenue Market Share by Application (2020-2025)
Table 14. Global mRNA Vaccines &Therapeutics Sale Price by Application (2020-2025) & (USD/Doses)
Table 15. Global mRNA Vaccines &Therapeutics Sales by Company (2020-2025) & (M Doses)
Table 16. Global mRNA Vaccines &Therapeutics Sales Market Share by Company (2020-2025)
Table 17. Global mRNA Vaccines &Therapeutics Revenue by Company (2020-2025) & ($ millions)
Table 18. Global mRNA Vaccines &Therapeutics Revenue Market Share by Company (2020-2025)
Table 19. Global mRNA Vaccines &Therapeutics Sale Price by Company (2020-2025) & (USD/Doses)
Table 20. Key Manufacturers mRNA Vaccines &Therapeutics Producing Area Distribution and Sales Area
Table 21. Players mRNA Vaccines &Therapeutics Products Offered
Table 22. mRNA Vaccines &Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global mRNA Vaccines &Therapeutics Sales by Geographic Region (2020-2025) & (M Doses)
Table 26. Global mRNA Vaccines &Therapeutics Sales Market Share Geographic Region (2020-2025)
Table 27. Global mRNA Vaccines &Therapeutics Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global mRNA Vaccines &Therapeutics Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global mRNA Vaccines &Therapeutics Sales by Country/Region (2020-2025) & (M Doses)
Table 30. Global mRNA Vaccines &Therapeutics Sales Market Share by Country/Region (2020-2025)
Table 31. Global mRNA Vaccines &Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global mRNA Vaccines &Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas mRNA Vaccines &Therapeutics Sales by Country (2020-2025) & (M Doses)
Table 34. Americas mRNA Vaccines &Therapeutics Sales Market Share by Country (2020-2025)
Table 35. Americas mRNA Vaccines &Therapeutics Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas mRNA Vaccines &Therapeutics Sales byType (2020-2025) & (M Doses)
Table 37. Americas mRNA Vaccines &Therapeutics Sales by Application (2020-2025) & (M Doses)
Table 38. APAC mRNA Vaccines &Therapeutics Sales by Region (2020-2025) & (M Doses)
Table 39. APAC mRNA Vaccines &Therapeutics Sales Market Share by Region (2020-2025)
Table 40. APAC mRNA Vaccines &Therapeutics Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC mRNA Vaccines &Therapeutics Sales byType (2020-2025) & (M Doses)
Table 42. APAC mRNA Vaccines &Therapeutics Sales by Application (2020-2025) & (M Doses)
Table 43. Europe mRNA Vaccines &Therapeutics Sales by Country (2020-2025) & (M Doses)
Table 44. Europe mRNA Vaccines &Therapeutics Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe mRNA Vaccines &Therapeutics Sales byType (2020-2025) & (M Doses)
Table 46. Europe mRNA Vaccines &Therapeutics Sales by Application (2020-2025) & (M Doses)
Table 47. Middle East & Africa mRNA Vaccines &Therapeutics Sales by Country (2020-2025) & (M Doses)
Table 48. Middle East & Africa mRNA Vaccines &Therapeutics Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa mRNA Vaccines &Therapeutics Sales byType (2020-2025) & (M Doses)
Table 50. Middle East & Africa mRNA Vaccines &Therapeutics Sales by Application (2020-2025) & (M Doses)
Table 51. Key Market Drivers & Growth Opportunities of mRNA Vaccines &Therapeutics
Table 52. Key Market Challenges & Risks of mRNA Vaccines &Therapeutics
Table 53. Key IndustryTrends of mRNA Vaccines &Therapeutics
Table 54. mRNA Vaccines &Therapeutics Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. mRNA Vaccines &Therapeutics Distributors List
Table 57. mRNA Vaccines &Therapeutics Customer List
Table 58. Global mRNA Vaccines &Therapeutics SalesForecast by Region (2026-2031) & (M Doses)
Table 59. Global mRNA Vaccines &Therapeutics RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas mRNA Vaccines &Therapeutics SalesForecast by Country (2026-2031) & (M Doses)
Table 61. Americas mRNA Vaccines &Therapeutics Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC mRNA Vaccines &Therapeutics SalesForecast by Region (2026-2031) & (M Doses)
Table 63. APAC mRNA Vaccines &Therapeutics Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe mRNA Vaccines &Therapeutics SalesForecast by Country (2026-2031) & (M Doses)
Table 65. Europe mRNA Vaccines &Therapeutics RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa mRNA Vaccines &Therapeutics SalesForecast by Country (2026-2031) & (M Doses)
Table 67. Middle East & Africa mRNA Vaccines &Therapeutics RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global mRNA Vaccines &Therapeutics SalesForecast byType (2026-2031) & (M Doses)
Table 69. Global mRNA Vaccines &Therapeutics RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global mRNA Vaccines &Therapeutics SalesForecast by Application (2026-2031) & (M Doses)
Table 71. Global mRNA Vaccines &Therapeutics RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. ModernaTherapeutics Basic Information, mRNA Vaccines &Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 73. ModernaTherapeutics mRNA Vaccines &Therapeutics Product Portfolios and Specifications
Table 74. ModernaTherapeutics mRNA Vaccines &Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 75. ModernaTherapeutics Main Business
Table 76. ModernaTherapeutics Latest Developments
Table 77. CureVac Basic Information, mRNA Vaccines &Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 78. CureVac mRNA Vaccines &Therapeutics Product Portfolios and Specifications
Table 79. CureVac mRNA Vaccines &Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 80. CureVac Main Business
Table 81. CureVac Latest Developments
Table 82.Translate Bio Basic Information, mRNA Vaccines &Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 83.Translate Bio mRNA Vaccines &Therapeutics Product Portfolios and Specifications
Table 84.Translate Bio mRNA Vaccines &Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 85.Translate Bio Main Business
Table 86.Translate Bio Latest Developments
Table 87. BioNTech Basic Information, mRNA Vaccines &Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 88. BioNTech mRNA Vaccines &Therapeutics Product Portfolios and Specifications
Table 89. BioNTech mRNA Vaccines &Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 90. BioNTech Main Business
Table 91. BioNTech Latest Developments
Table 92. SangamoTherapeutics Basic Information, mRNA Vaccines &Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 93. SangamoTherapeutics mRNA Vaccines &Therapeutics Product Portfolios and Specifications
Table 94. SangamoTherapeutics mRNA Vaccines &Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 95. SangamoTherapeutics Main Business
Table 96. SangamoTherapeutics Latest Developments
Table 97. ArgosTherapeutics Basic Information, mRNA Vaccines &Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 98. ArgosTherapeutics mRNA Vaccines &Therapeutics Product Portfolios and Specifications
Table 99. ArgosTherapeutics mRNA Vaccines &Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 100. ArgosTherapeutics Main Business
Table 101. ArgosTherapeutics Latest Developments
Table 102. In-Cell-Art Basic Information, mRNA Vaccines &Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 103. In-Cell-Art mRNA Vaccines &Therapeutics Product Portfolios and Specifications
Table 104. In-Cell-Art mRNA Vaccines &Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 105. In-Cell-Art Main Business
Table 106. In-Cell-Art Latest Developments
Table 107. eTheRNA Basic Information, mRNA Vaccines &Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 108. eTheRNA mRNA Vaccines &Therapeutics Product Portfolios and Specifications
Table 109. eTheRNA mRNA Vaccines &Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 110. eTheRNA Main Business
Table 111. eTheRNA Latest Developments
Table 112. Ethris Basic Information, mRNA Vaccines &Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 113. Ethris mRNA Vaccines &Therapeutics Product Portfolios and Specifications
Table 114. Ethris mRNA Vaccines &Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 115. Ethris Main Business
Table 116. Ethris Latest Developments
Table 117.Tiba Biotechnology Basic Information, mRNA Vaccines &Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 118.Tiba Biotechnology mRNA Vaccines &Therapeutics Product Portfolios and Specifications
Table 119.Tiba Biotechnology mRNA Vaccines &Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 120.Tiba Biotechnology Main Business
Table 121.Tiba Biotechnology Latest Developments
LIST OFFIGURES
Figure 1. Picture of mRNA Vaccines &Therapeutics
Figure 2. mRNA Vaccines &Therapeutics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global mRNA Vaccines &Therapeutics Sales Growth Rate 2020-2031 (M Doses)
Figure 7. Global mRNA Vaccines &Therapeutics Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. mRNA Vaccines &Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. mRNA Vaccines &Therapeutics Sales Market Share by Country/Region (2024)
Figure 10. mRNA Vaccines &Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Infectious Disease Vaccines
Figure 12. Product Picture of Cancer Vaccines
Figure 13. Global mRNA Vaccines &Therapeutics Sales Market Share byType in 2025
Figure 14. Global mRNA Vaccines &Therapeutics Revenue Market Share byType (2020-2025)
Figure 15. mRNA Vaccines &Therapeutics Consumed in Infectious Disease
Figure 16. Global mRNA Vaccines &Therapeutics Market: Infectious Disease (2020-2025) & (M Doses)
Figure 17. mRNA Vaccines &Therapeutics Consumed in Cancer
Figure 18. Global mRNA Vaccines &Therapeutics Market: Cancer (2020-2025) & (M Doses)
Figure 19. Global mRNA Vaccines &Therapeutics Sale Market Share by Application (2024)
Figure 20. Global mRNA Vaccines &Therapeutics Revenue Market Share by Application in 2025
Figure 21. mRNA Vaccines &Therapeutics Sales by Company in 2025 (M Doses)
Figure 22. Global mRNA Vaccines &Therapeutics Sales Market Share by Company in 2025
Figure 23. mRNA Vaccines &Therapeutics Revenue by Company in 2025 ($ millions)
Figure 24. Global mRNA Vaccines &Therapeutics Revenue Market Share by Company in 2025
Figure 25. Global mRNA Vaccines &Therapeutics Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global mRNA Vaccines &Therapeutics Revenue Market Share by Geographic Region in 2025
Figure 27. Americas mRNA Vaccines &Therapeutics Sales 2020-2025 (M Doses)
Figure 28. Americas mRNA Vaccines &Therapeutics Revenue 2020-2025 ($ millions)
Figure 29. APAC mRNA Vaccines &Therapeutics Sales 2020-2025 (M Doses)
Figure 30. APAC mRNA Vaccines &Therapeutics Revenue 2020-2025 ($ millions)
Figure 31. Europe mRNA Vaccines &Therapeutics Sales 2020-2025 (M Doses)
Figure 32. Europe mRNA Vaccines &Therapeutics Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa mRNA Vaccines &Therapeutics Sales 2020-2025 (M Doses)
Figure 34. Middle East & Africa mRNA Vaccines &Therapeutics Revenue 2020-2025 ($ millions)
Figure 35. Americas mRNA Vaccines &Therapeutics Sales Market Share by Country in 2025
Figure 36. Americas mRNA Vaccines &Therapeutics Revenue Market Share by Country (2020-2025)
Figure 37. Americas mRNA Vaccines &Therapeutics Sales Market Share byType (2020-2025)
Figure 38. Americas mRNA Vaccines &Therapeutics Sales Market Share by Application (2020-2025)
Figure 39. United States mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC mRNA Vaccines &Therapeutics Sales Market Share by Region in 2025
Figure 44. APAC mRNA Vaccines &Therapeutics Revenue Market Share by Region (2020-2025)
Figure 45. APAC mRNA Vaccines &Therapeutics Sales Market Share byType (2020-2025)
Figure 46. APAC mRNA Vaccines &Therapeutics Sales Market Share by Application (2020-2025)
Figure 47. China mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 51. India mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe mRNA Vaccines &Therapeutics Sales Market Share by Country in 2025
Figure 55. Europe mRNA Vaccines &Therapeutics Revenue Market Share by Country (2020-2025)
Figure 56. Europe mRNA Vaccines &Therapeutics Sales Market Share byType (2020-2025)
Figure 57. Europe mRNA Vaccines &Therapeutics Sales Market Share by Application (2020-2025)
Figure 58. Germany mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 59.France mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 60. UK mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa mRNA Vaccines &Therapeutics Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa mRNA Vaccines &Therapeutics Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa mRNA Vaccines &Therapeutics Sales Market Share by Application (2020-2025)
Figure 66. Egypt mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of mRNA Vaccines &Therapeutics in 2025
Figure 72. Manufacturing Process Analysis of mRNA Vaccines &Therapeutics
Figure 73. Industry Chain Structure of mRNA Vaccines &Therapeutics
Figure 74. Channels of Distribution
Figure 75. Global mRNA Vaccines &Therapeutics Sales MarketForecast by Region (2026-2031)
Figure 76. Global mRNA Vaccines &Therapeutics Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global mRNA Vaccines &Therapeutics Sales Market ShareForecast byType (2026-2031)
Figure 78. Global mRNA Vaccines &Therapeutics Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global mRNA Vaccines &Therapeutics Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global mRNA Vaccines &Therapeutics Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global mRNA Vaccines & Therapeutics Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for mRNA Vaccines & Therapeutics by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for mRNA Vaccines & Therapeutics by Country/Region, 2020, 2024 & 2031
2.2 mRNA Vaccines & Therapeutics Segment by Type
2.2.1 Infectious Disease Vaccines
2.2.2 Cancer Vaccines
2.3 mRNA Vaccines & Therapeutics Sales by Type
2.3.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2020-2025)
2.3.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2020-2025)
2.3.3 Global mRNA Vaccines & Therapeutics Sale Price by Type (2020-2025)
2.4 mRNA Vaccines & Therapeutics Segment by Application
2.4.1 Infectious Disease
2.4.2 Cancer
2.5 mRNA Vaccines & Therapeutics Sales by Application
2.5.1 Global mRNA Vaccines & Therapeutics Sale Market Share by Application (2020-2025)
2.5.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Application (2020-2025)
2.5.3 Global mRNA Vaccines & Therapeutics Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global mRNA Vaccines & Therapeutics Breakdown Data by Company
3.1.1 Global mRNA Vaccines & Therapeutics Annual Sales by Company (2020-2025)
3.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Company (2020-2025)
3.2 Global mRNA Vaccines & Therapeutics Annual Revenue by Company (2020-2025)
3.2.1 Global mRNA Vaccines & Therapeutics Revenue by Company (2020-2025)
3.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Company (2020-2025)
3.3 Global mRNA Vaccines & Therapeutics Sale Price by Company
3.4 Key Manufacturers mRNA Vaccines & Therapeutics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers mRNA Vaccines & Therapeutics Product Location Distribution
3.4.2 Players mRNA Vaccines & Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MRNA VACCINES & THERAPEUTICS BY GEOGRAPHIC REGION
4.1 World Historic mRNA Vaccines & Therapeutics Market Size by Geographic Region (2020-2025)
4.1.1 Global mRNA Vaccines & Therapeutics Annual Sales by Geographic Region (2020-2025)
4.1.2 Global mRNA Vaccines & Therapeutics Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic mRNA Vaccines & Therapeutics Market Size by Country/Region (2020-2025)
4.2.1 Global mRNA Vaccines & Therapeutics Annual Sales by Country/Region (2020-2025)
4.2.2 Global mRNA Vaccines & Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas mRNA Vaccines & Therapeutics Sales Growth
4.4 APAC mRNA Vaccines & Therapeutics Sales Growth
4.5 Europe mRNA Vaccines & Therapeutics Sales Growth
4.6 Middle East & Africa mRNA Vaccines & Therapeutics Sales Growth
5 AMERICAS
5.1 Americas mRNA Vaccines & Therapeutics Sales by Country
5.1.1 Americas mRNA Vaccines & Therapeutics Sales by Country (2020-2025)
5.1.2 Americas mRNA Vaccines & Therapeutics Revenue by Country (2020-2025)
5.2 Americas mRNA Vaccines & Therapeutics Sales by Type (2020-2025)
5.3 Americas mRNA Vaccines & Therapeutics Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Vaccines & Therapeutics Sales by Region
6.1.1 APAC mRNA Vaccines & Therapeutics Sales by Region (2020-2025)
6.1.2 APAC mRNA Vaccines & Therapeutics Revenue by Region (2020-2025)
6.2 APAC mRNA Vaccines & Therapeutics Sales by Type (2020-2025)
6.3 APAC mRNA Vaccines & Therapeutics Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe mRNA Vaccines & Therapeutics by Country
7.1.1 Europe mRNA Vaccines & Therapeutics Sales by Country (2020-2025)
7.1.2 Europe mRNA Vaccines & Therapeutics Revenue by Country (2020-2025)
7.2 Europe mRNA Vaccines & Therapeutics Sales by Type (2020-2025)
7.3 Europe mRNA Vaccines & Therapeutics Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa mRNA Vaccines & Therapeutics by Country
8.1.1 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Country (2020-2025)
8.1.2 Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country (2020-2025)
8.2 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Type (2020-2025)
8.3 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of mRNA Vaccines & Therapeutics
10.3 Manufacturing Process Analysis of mRNA Vaccines & Therapeutics
10.4 Industry Chain Structure of mRNA Vaccines & Therapeutics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 mRNA Vaccines & Therapeutics Distributors
11.3 mRNA Vaccines & Therapeutics Customer
12 WORLD FORECAST REVIEW FOR MRNA VACCINES & THERAPEUTICS BY GEOGRAPHIC REGION
12.1 Global mRNA Vaccines & Therapeutics Market Size Forecast by Region
12.1.1 Global mRNA Vaccines & Therapeutics Forecast by Region (2026-2031)
12.1.2 Global mRNA Vaccines & Therapeutics Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global mRNA Vaccines & Therapeutics Forecast by Type (2026-2031)
12.7 Global mRNA Vaccines & Therapeutics Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Moderna Therapeutics
13.1.1 Moderna Therapeutics Company Information
13.1.2 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Portfolios and Specifications
13.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Moderna Therapeutics Main Business Overview
13.1.5 Moderna Therapeutics Latest Developments
13.2 CureVac
13.2.1 CureVac Company Information
13.2.2 CureVac mRNA Vaccines & Therapeutics Product Portfolios and Specifications
13.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 CureVac Main Business Overview
13.2.5 CureVac Latest Developments
13.3 Translate Bio
13.3.1 Translate Bio Company Information
13.3.2 Translate Bio mRNA Vaccines & Therapeutics Product Portfolios and Specifications
13.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Translate Bio Main Business Overview
13.3.5 Translate Bio Latest Developments
13.4 BioNTech
13.4.1 BioNTech Company Information
13.4.2 BioNTech mRNA Vaccines & Therapeutics Product Portfolios and Specifications
13.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 BioNTech Main Business Overview
13.4.5 BioNTech Latest Developments
13.5 Sangamo Therapeutics
13.5.1 Sangamo Therapeutics Company Information
13.5.2 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Portfolios and Specifications
13.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Sangamo Therapeutics Main Business Overview
13.5.5 Sangamo Therapeutics Latest Developments
13.6 Argos Therapeutics
13.6.1 Argos Therapeutics Company Information
13.6.2 Argos Therapeutics mRNA Vaccines & Therapeutics Product Portfolios and Specifications
13.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Argos Therapeutics Main Business Overview
13.6.5 Argos Therapeutics Latest Developments
13.7 In-Cell-Art
13.7.1 In-Cell-Art Company Information
13.7.2 In-Cell-Art mRNA Vaccines & Therapeutics Product Portfolios and Specifications
13.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 In-Cell-Art Main Business Overview
13.7.5 In-Cell-Art Latest Developments
13.8 eTheRNA
13.8.1 eTheRNA Company Information
13.8.2 eTheRNA mRNA Vaccines & Therapeutics Product Portfolios and Specifications
13.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 eTheRNA Main Business Overview
13.8.5 eTheRNA Latest Developments
13.9 Ethris
13.9.1 Ethris Company Information
13.9.2 Ethris mRNA Vaccines & Therapeutics Product Portfolios and Specifications
13.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Ethris Main Business Overview
13.9.5 Ethris Latest Developments
13.10 Tiba Biotechnology
13.10.1 Tiba Biotechnology Company Information
13.10.2 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Portfolios and Specifications
13.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Tiba Biotechnology Main Business Overview
13.10.5 Tiba Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. mRNA Vaccines &Therapeutics Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. mRNA Vaccines &Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Infectious Disease Vaccines
Table 4. Major Players of Cancer Vaccines
Table 5. Global mRNA Vaccines &Therapeutics Sales byType (2020-2025) & (M Doses)
Table 6. Global mRNA Vaccines &Therapeutics Sales Market Share byType (2020-2025)
Table 7. Global mRNA Vaccines &Therapeutics Revenue byType (2020-2025) & ($ million)
Table 8. Global mRNA Vaccines &Therapeutics Revenue Market Share byType (2020-2025)
Table 9. Global mRNA Vaccines &Therapeutics Sale Price byType (2020-2025) & (USD/Doses)
Table 10. Global mRNA Vaccines &Therapeutics Sale by Application (2020-2025) & (M Doses)
Table 11. Global mRNA Vaccines &Therapeutics Sale Market Share by Application (2020-2025)
Table 12. Global mRNA Vaccines &Therapeutics Revenue by Application (2020-2025) & ($ million)
Table 13. Global mRNA Vaccines &Therapeutics Revenue Market Share by Application (2020-2025)
Table 14. Global mRNA Vaccines &Therapeutics Sale Price by Application (2020-2025) & (USD/Doses)
Table 15. Global mRNA Vaccines &Therapeutics Sales by Company (2020-2025) & (M Doses)
Table 16. Global mRNA Vaccines &Therapeutics Sales Market Share by Company (2020-2025)
Table 17. Global mRNA Vaccines &Therapeutics Revenue by Company (2020-2025) & ($ millions)
Table 18. Global mRNA Vaccines &Therapeutics Revenue Market Share by Company (2020-2025)
Table 19. Global mRNA Vaccines &Therapeutics Sale Price by Company (2020-2025) & (USD/Doses)
Table 20. Key Manufacturers mRNA Vaccines &Therapeutics Producing Area Distribution and Sales Area
Table 21. Players mRNA Vaccines &Therapeutics Products Offered
Table 22. mRNA Vaccines &Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global mRNA Vaccines &Therapeutics Sales by Geographic Region (2020-2025) & (M Doses)
Table 26. Global mRNA Vaccines &Therapeutics Sales Market Share Geographic Region (2020-2025)
Table 27. Global mRNA Vaccines &Therapeutics Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global mRNA Vaccines &Therapeutics Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global mRNA Vaccines &Therapeutics Sales by Country/Region (2020-2025) & (M Doses)
Table 30. Global mRNA Vaccines &Therapeutics Sales Market Share by Country/Region (2020-2025)
Table 31. Global mRNA Vaccines &Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global mRNA Vaccines &Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas mRNA Vaccines &Therapeutics Sales by Country (2020-2025) & (M Doses)
Table 34. Americas mRNA Vaccines &Therapeutics Sales Market Share by Country (2020-2025)
Table 35. Americas mRNA Vaccines &Therapeutics Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas mRNA Vaccines &Therapeutics Sales byType (2020-2025) & (M Doses)
Table 37. Americas mRNA Vaccines &Therapeutics Sales by Application (2020-2025) & (M Doses)
Table 38. APAC mRNA Vaccines &Therapeutics Sales by Region (2020-2025) & (M Doses)
Table 39. APAC mRNA Vaccines &Therapeutics Sales Market Share by Region (2020-2025)
Table 40. APAC mRNA Vaccines &Therapeutics Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC mRNA Vaccines &Therapeutics Sales byType (2020-2025) & (M Doses)
Table 42. APAC mRNA Vaccines &Therapeutics Sales by Application (2020-2025) & (M Doses)
Table 43. Europe mRNA Vaccines &Therapeutics Sales by Country (2020-2025) & (M Doses)
Table 44. Europe mRNA Vaccines &Therapeutics Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe mRNA Vaccines &Therapeutics Sales byType (2020-2025) & (M Doses)
Table 46. Europe mRNA Vaccines &Therapeutics Sales by Application (2020-2025) & (M Doses)
Table 47. Middle East & Africa mRNA Vaccines &Therapeutics Sales by Country (2020-2025) & (M Doses)
Table 48. Middle East & Africa mRNA Vaccines &Therapeutics Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa mRNA Vaccines &Therapeutics Sales byType (2020-2025) & (M Doses)
Table 50. Middle East & Africa mRNA Vaccines &Therapeutics Sales by Application (2020-2025) & (M Doses)
Table 51. Key Market Drivers & Growth Opportunities of mRNA Vaccines &Therapeutics
Table 52. Key Market Challenges & Risks of mRNA Vaccines &Therapeutics
Table 53. Key IndustryTrends of mRNA Vaccines &Therapeutics
Table 54. mRNA Vaccines &Therapeutics Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. mRNA Vaccines &Therapeutics Distributors List
Table 57. mRNA Vaccines &Therapeutics Customer List
Table 58. Global mRNA Vaccines &Therapeutics SalesForecast by Region (2026-2031) & (M Doses)
Table 59. Global mRNA Vaccines &Therapeutics RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas mRNA Vaccines &Therapeutics SalesForecast by Country (2026-2031) & (M Doses)
Table 61. Americas mRNA Vaccines &Therapeutics Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC mRNA Vaccines &Therapeutics SalesForecast by Region (2026-2031) & (M Doses)
Table 63. APAC mRNA Vaccines &Therapeutics Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe mRNA Vaccines &Therapeutics SalesForecast by Country (2026-2031) & (M Doses)
Table 65. Europe mRNA Vaccines &Therapeutics RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa mRNA Vaccines &Therapeutics SalesForecast by Country (2026-2031) & (M Doses)
Table 67. Middle East & Africa mRNA Vaccines &Therapeutics RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global mRNA Vaccines &Therapeutics SalesForecast byType (2026-2031) & (M Doses)
Table 69. Global mRNA Vaccines &Therapeutics RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global mRNA Vaccines &Therapeutics SalesForecast by Application (2026-2031) & (M Doses)
Table 71. Global mRNA Vaccines &Therapeutics RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. ModernaTherapeutics Basic Information, mRNA Vaccines &Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 73. ModernaTherapeutics mRNA Vaccines &Therapeutics Product Portfolios and Specifications
Table 74. ModernaTherapeutics mRNA Vaccines &Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 75. ModernaTherapeutics Main Business
Table 76. ModernaTherapeutics Latest Developments
Table 77. CureVac Basic Information, mRNA Vaccines &Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 78. CureVac mRNA Vaccines &Therapeutics Product Portfolios and Specifications
Table 79. CureVac mRNA Vaccines &Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 80. CureVac Main Business
Table 81. CureVac Latest Developments
Table 82.Translate Bio Basic Information, mRNA Vaccines &Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 83.Translate Bio mRNA Vaccines &Therapeutics Product Portfolios and Specifications
Table 84.Translate Bio mRNA Vaccines &Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 85.Translate Bio Main Business
Table 86.Translate Bio Latest Developments
Table 87. BioNTech Basic Information, mRNA Vaccines &Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 88. BioNTech mRNA Vaccines &Therapeutics Product Portfolios and Specifications
Table 89. BioNTech mRNA Vaccines &Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 90. BioNTech Main Business
Table 91. BioNTech Latest Developments
Table 92. SangamoTherapeutics Basic Information, mRNA Vaccines &Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 93. SangamoTherapeutics mRNA Vaccines &Therapeutics Product Portfolios and Specifications
Table 94. SangamoTherapeutics mRNA Vaccines &Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 95. SangamoTherapeutics Main Business
Table 96. SangamoTherapeutics Latest Developments
Table 97. ArgosTherapeutics Basic Information, mRNA Vaccines &Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 98. ArgosTherapeutics mRNA Vaccines &Therapeutics Product Portfolios and Specifications
Table 99. ArgosTherapeutics mRNA Vaccines &Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 100. ArgosTherapeutics Main Business
Table 101. ArgosTherapeutics Latest Developments
Table 102. In-Cell-Art Basic Information, mRNA Vaccines &Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 103. In-Cell-Art mRNA Vaccines &Therapeutics Product Portfolios and Specifications
Table 104. In-Cell-Art mRNA Vaccines &Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 105. In-Cell-Art Main Business
Table 106. In-Cell-Art Latest Developments
Table 107. eTheRNA Basic Information, mRNA Vaccines &Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 108. eTheRNA mRNA Vaccines &Therapeutics Product Portfolios and Specifications
Table 109. eTheRNA mRNA Vaccines &Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 110. eTheRNA Main Business
Table 111. eTheRNA Latest Developments
Table 112. Ethris Basic Information, mRNA Vaccines &Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 113. Ethris mRNA Vaccines &Therapeutics Product Portfolios and Specifications
Table 114. Ethris mRNA Vaccines &Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 115. Ethris Main Business
Table 116. Ethris Latest Developments
Table 117.Tiba Biotechnology Basic Information, mRNA Vaccines &Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 118.Tiba Biotechnology mRNA Vaccines &Therapeutics Product Portfolios and Specifications
Table 119.Tiba Biotechnology mRNA Vaccines &Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 120.Tiba Biotechnology Main Business
Table 121.Tiba Biotechnology Latest Developments
LIST OFFIGURES
Figure 1. Picture of mRNA Vaccines &Therapeutics
Figure 2. mRNA Vaccines &Therapeutics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global mRNA Vaccines &Therapeutics Sales Growth Rate 2020-2031 (M Doses)
Figure 7. Global mRNA Vaccines &Therapeutics Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. mRNA Vaccines &Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. mRNA Vaccines &Therapeutics Sales Market Share by Country/Region (2024)
Figure 10. mRNA Vaccines &Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Infectious Disease Vaccines
Figure 12. Product Picture of Cancer Vaccines
Figure 13. Global mRNA Vaccines &Therapeutics Sales Market Share byType in 2025
Figure 14. Global mRNA Vaccines &Therapeutics Revenue Market Share byType (2020-2025)
Figure 15. mRNA Vaccines &Therapeutics Consumed in Infectious Disease
Figure 16. Global mRNA Vaccines &Therapeutics Market: Infectious Disease (2020-2025) & (M Doses)
Figure 17. mRNA Vaccines &Therapeutics Consumed in Cancer
Figure 18. Global mRNA Vaccines &Therapeutics Market: Cancer (2020-2025) & (M Doses)
Figure 19. Global mRNA Vaccines &Therapeutics Sale Market Share by Application (2024)
Figure 20. Global mRNA Vaccines &Therapeutics Revenue Market Share by Application in 2025
Figure 21. mRNA Vaccines &Therapeutics Sales by Company in 2025 (M Doses)
Figure 22. Global mRNA Vaccines &Therapeutics Sales Market Share by Company in 2025
Figure 23. mRNA Vaccines &Therapeutics Revenue by Company in 2025 ($ millions)
Figure 24. Global mRNA Vaccines &Therapeutics Revenue Market Share by Company in 2025
Figure 25. Global mRNA Vaccines &Therapeutics Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global mRNA Vaccines &Therapeutics Revenue Market Share by Geographic Region in 2025
Figure 27. Americas mRNA Vaccines &Therapeutics Sales 2020-2025 (M Doses)
Figure 28. Americas mRNA Vaccines &Therapeutics Revenue 2020-2025 ($ millions)
Figure 29. APAC mRNA Vaccines &Therapeutics Sales 2020-2025 (M Doses)
Figure 30. APAC mRNA Vaccines &Therapeutics Revenue 2020-2025 ($ millions)
Figure 31. Europe mRNA Vaccines &Therapeutics Sales 2020-2025 (M Doses)
Figure 32. Europe mRNA Vaccines &Therapeutics Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa mRNA Vaccines &Therapeutics Sales 2020-2025 (M Doses)
Figure 34. Middle East & Africa mRNA Vaccines &Therapeutics Revenue 2020-2025 ($ millions)
Figure 35. Americas mRNA Vaccines &Therapeutics Sales Market Share by Country in 2025
Figure 36. Americas mRNA Vaccines &Therapeutics Revenue Market Share by Country (2020-2025)
Figure 37. Americas mRNA Vaccines &Therapeutics Sales Market Share byType (2020-2025)
Figure 38. Americas mRNA Vaccines &Therapeutics Sales Market Share by Application (2020-2025)
Figure 39. United States mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC mRNA Vaccines &Therapeutics Sales Market Share by Region in 2025
Figure 44. APAC mRNA Vaccines &Therapeutics Revenue Market Share by Region (2020-2025)
Figure 45. APAC mRNA Vaccines &Therapeutics Sales Market Share byType (2020-2025)
Figure 46. APAC mRNA Vaccines &Therapeutics Sales Market Share by Application (2020-2025)
Figure 47. China mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 51. India mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe mRNA Vaccines &Therapeutics Sales Market Share by Country in 2025
Figure 55. Europe mRNA Vaccines &Therapeutics Revenue Market Share by Country (2020-2025)
Figure 56. Europe mRNA Vaccines &Therapeutics Sales Market Share byType (2020-2025)
Figure 57. Europe mRNA Vaccines &Therapeutics Sales Market Share by Application (2020-2025)
Figure 58. Germany mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 59.France mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 60. UK mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa mRNA Vaccines &Therapeutics Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa mRNA Vaccines &Therapeutics Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa mRNA Vaccines &Therapeutics Sales Market Share by Application (2020-2025)
Figure 66. Egypt mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries mRNA Vaccines &Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of mRNA Vaccines &Therapeutics in 2025
Figure 72. Manufacturing Process Analysis of mRNA Vaccines &Therapeutics
Figure 73. Industry Chain Structure of mRNA Vaccines &Therapeutics
Figure 74. Channels of Distribution
Figure 75. Global mRNA Vaccines &Therapeutics Sales MarketForecast by Region (2026-2031)
Figure 76. Global mRNA Vaccines &Therapeutics Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global mRNA Vaccines &Therapeutics Sales Market ShareForecast byType (2026-2031)
Figure 78. Global mRNA Vaccines &Therapeutics Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global mRNA Vaccines &Therapeutics Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global mRNA Vaccines &Therapeutics Revenue Market ShareForecast by Application (2026-2031)
